Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-10

Clinical Trial Update: Naltrexone and Memantine Effects on Alcohol Drinking Behaviors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating naltrexone and memantine effects on alcohol drinking behaviors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: Yale University | Conditions: Alcohol Drinking | Phase 2 | Status: COMPLETED | Results posted: 2019-07-10